Magnesium sulphate in women at risk of preterm birth for fetal neuroprotection - an individual patient data review

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/627228

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Infants born preterm are at high risk of dying and survivors have a higher risk of neurological problems. Evidence suggests that giving magnesium sulphate to women at risk of preterm birth prior to delivery reduces cerebral palsy in surviving children. It is unclear which women may benefit, what dose and when prior to birth should magnesium sulphate be given. This review will determine how individual women should be treated with magnesium to help protect the brain of a baby born too soon.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $276,002.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epidemiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Randomised clinical trials | cerebral palsy | individual patient data meta-analysis | magnesium sulphate | neuroprotection | preterm birth | systematic review

Related Links